Zenas BioPharma

US · ZBIO #2856 by market cap Listed 2024

28.18 +1.24 +4.60%

Live - 5344 symbols - heartbeat 313s ago · 2026-10-08 07:09

Pre-market 28.26 +0.28%

After-hours 28.18 0.00%

Market cap: 1.84B
P/E (TTM): -2.93
P/B: 7.43
EPS: -8.44
Div yield: 0.00%
52W pos: 47%

Reader sentiment Are you bullish or bearish on ZBIO?

Anonymous reader poll. Unscientific, not investment advice.

About Zenas BioPharma

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.

Founded: 2019
CEO: Mr. Leon Oliver Moulder, Jr
Employees: 167
Headquarters: Waltham, Massachusetts, United States of America
Fiscal year end: 12-31
Website: zenasbio.com

Company profile

Exchange: US
Symbol: ZBIO
Market-cap rank: #2856
Listing date: 2024-09-13
Market cap: 1.84B
Float cap: 1.12B
Shares out: 65.18M
Float shares: 39.84M

Sectors & themes

Biotechnology

Browse all sectors & themes

Quote time 2026-10-08 07:09:11 · For reference only, not investment advice and not tailored to your situation.